Aditya Birla Sun Life Pharma and Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Fund | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹227 Cr | ₹830 Cr |
| Min Investment | ₹5000 | ₹1000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 08 Nov 2021 | 10 Jul 2019 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 31% |
| Expense Ratio | 2.35 | 2.27 |
| Manager | Rohan Korde | Dhaval Joshi |
| ISIN Code | INF00XX01BL5 | INF209KB1N91 |
| Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Month | 0.77% | -0.13% |
| 6 Month | 3.16% | 4.85% |
| 1 Year | -4.23% | -0.83% |
| 3 Year | 18.61% | 20.44% |
| 5 Year | - | 15.7% |
SIP Return Analysis
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 6 Month | 0.5% | 0.79% |
| 1 Year | 2.76% | 5.55% |
| 3 Year | 16.71% | 17.45% |
| 5 Year | - | 15.72% |
Rolling Lumpsum Returns
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| 1 Year | 18.94% | 23.67% |
| 3 Year | 20.21% | 17.01% |
| 5 Year | - | 21.83% |
Risk Management
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Standard Deviation | 15.64% | 16.01% |
| Sharp | 0.77% | 0.85% |
| Beta | 0.95% | 0.96% |
| Alpha | -2.74% | -1.37% |
Fund Managers
| Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Name | Rohan Korde | Dhaval Joshi |
| Total AUM | ₹4626 Cr | ₹361932 Cr |
| Funds Managed | 10 | 55 |
| ITI Pharma and Healthcare Fund Regular - Growth | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 3.56 | 4.88 |
| Large Cap | 29.45 | 25.69 |
| Mid Cap | 37.33 | 41.06 |
| Small Cap | 29.66 | 28.36 |
Sector Allocation
| Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
|---|---|---|
| Others | 1.52 | 1.66 |
| Healthcare | 91.78 | 97.35 |
| Basic Materials | 3.67 | 0.99 |
| Industrials | 1.86 | - |
| Financial Services | 1.17 | - |
Top Comparisons
ICICI Prudential Regular Savings Fund - Plan - Growth
3Y Returns10.15%
Canara Robeco Conservative Hybrid Fund - Regular Plan - Growth Option
3Y Returns8.27%
ITI Banking and Financial Services Fund Regular - Growth
3Y Returns13.41%
Baroda BNP Paribas Banking and Financial Services Fund - Regular - Growth Option
3Y Returns16.17%
ICICI Prudential Regular Savings Fund - Plan - Growth
3Y Returns10.15%
Nippon India Conservative Hybrid Fund - Regular - Growth
3Y Returns9.07%
Aditya Birla Sun Life Multi-Index Fund Of Fund-Regular Growth
3Y Returns17.31%
Tata Nifty India Digital ETF Fund of Fund -Regular Plan-Growth
3Y Returns17.49%